CClinicalTrials.gg
CompletedNCT07418255Anxiété-IDEUpdated Feb 18, 2026

Level of Anxiety Among Nurses Working in Psychiatric Settings

An observational study in Anxiety, sponsored by Université de Reims Champagne-Ardenne. Completed at 2 sites in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-18.

Sponsored by Université de Reims Champagne-Ardenne · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
543
Ages
18 Years and older
Sex
All
01

Study summary

Anxiety is common among healthcare professionals, particularly nurses, who are faced with major responsibilities and stressful situations. In psychiatric settings, this stress is exacerbated by exposure to patients with serious mental disorders (schizophrenia, bipolarity, personality disorders), who are often unpredictable and sometimes violent. Nurses in this sector face an increased risk of violence, work overload and an emotionally taxing environment, which can lead to chronic anxiety, burn-out and even mental health problems.

These professionals also have to manage the ambiguity of their role, between caring for and containing patients, in a context where training in crisis management is often inadequate.

Read the detailed description

The primary objective is to describe the level of anxiety in nurses practising in psychiatric settings.

The secondary objectives are :

  • describe the impact of anxiety levels on professional and personal life.
  • to identify the factors associated with anxiety levels in nurses working in psychiatry.
02

Conditions studied

  • Anxiety

Browse trials for

Keywords

  • Anxiety
  • healthcare professionals
  • nurse
  • psychiatry
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 543 is above the median of 150 across 606 observational studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Université de Reims Champagne-Ardenne is the lead sponsor of 62 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

State-registered nurse

Inclusion criteria

  • State-registered nurse,
  • Practising for more than one year in a psychiatric environment, whether in a full or partial hospitalisation unit, or in a medical-psychological centre
  • Whatever positions they previously held
  • Agreeing to take part in the study.

Exclusion criteria

Exclusion Criteria:

  • nursing students
  • Practising for less than a year in a psychiatric setting
  • Protected by law (guardianship, curatorship, safeguard of justice)
  • Refusing to take part in the study
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
543 participants (actual)
Patient registry
No

Interventions

  • Otherdata collection

    data collection

06

What researchers measure

Primary outcomes

  1. STAI Scale (State Trait Anxiety Inventory, Y-A form)

    the level of anxiety assessed by Spielberger's State Anxiety Inventory (STAI - Trait Anxiety Inventory Form Y-A scale). (12)

    Time frame: Day 0

07

Study locations

2 sites
  • Gestonnairedu CURRS
    Reims, Champagne-Ardenne 51100, France
  • Ufr Medecine Urca
    Reims, 51100, France
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07418255
Lead sponsor
Université de Reims Champagne-Ardenne
Responsible party
Sponsor
First posted
Feb 18, 2026
Start date
Feb 25, 2025
Primary completion
May 13, 2025
Completion
Jun 15, 2025
Last update
Feb 18, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion